SIDRA GILL, NOSHEEN YOUSUF, AMMARA NAWAZ, RABBEA NAZIR, MUZZAFFAR GILL Background: ERCP is commonly performed in cirrhotics, they are at increased risk of bleeding after ERCP, but the incidence and risk-factors in this population is not well described. The aim of this study was to examine the incidence of post-ERCP complications. Methods: We evaluated all […]

SIDRA GILL, NOSHEEN YOUSAF, FAIZA IRFAN, AMMARA NAWAZ, UZMA FEYAZ QAZI, MUZZAFFAR GILL MAROOF INTERNATIONAL HOSPITAL, ISLAMABAD, PAKISTAN Background and Aims: Sofosbuvir + Ribavirin is gold standard for chronic HEP-C patients. We evaluated the safety and efficacy of sofosbuvir and ribavirin in chronic HEP-C G3 patients. Methods: We prospectively enrolled 150 patients with chronic HEP- […]

SIDRA GILL NOSHEEN YOUSUF, AMMARA NAWAZ , RABBEA NAZIR, MUZZAFFAR GILL Background: Recurrent hepatitis occurs in the vast majority of HCV-positive recipients who are viremic at the time of Liver Transplantation (LT). We evaluated safety and efficacy of all oral antiviral therapy (Tx) with Sofosbuvir plus Ribavirin in a population of HCV G3-infected patients. Methods: […]

SIDRA GILL, NOSHEEN YOUSAF, FAIZA IRFAN, AMMARA NAWAZ, UZMA FEYAZ QAZI, MUZZAFFAR GILL MAROOF INTERNATIONAL HOSPITAL, ISLAMABAD, PAKISTAN Background: Sovaldi, Ribavirin and PEG-Interferon is gold standard therapy for chronic HEP-C patients. It is recommended both for treatment naive and experienced patients. We evaluated the safety and efficacy of this combination in naïve chronic HEP-C G3 […]

Certificate of APASL, Awarded to Prof. Muzzaffar Gill for Moderating Conference.

Professor Gill's team has presented four research research papers In 25th Asian Pacific association for study of liver diseases (APASL) Which was held in Tokyo Japan from Feb 20-24 , 2016 On behalf of the 25th Asian Pacific Association for the Study of the Liver (APASL 2016) "Modern Hepatology", that will be held on February […]

Professor Gill team has presented a research work in 23rd United European gastroenterology week, October 24 -28 ,2015 | Barcelona, Spain Dear Dr Gill, On behalf of the United European Gastroenterology, I would like to thank you for your contribution to our annual congress taking place from October 24 to 28, 2015 in Barcelona. As […]

Professor Gill is invited by EASL Governing board for participation in EASL 50th Anniversary conference being held in Vienna, Austria from April 22, 2015. EASL Business Meeting Invitation 2015 Dear Prof. Gill 2015 is a very special year for EASL as we are celebrating our 50th annual meeting and the 30th anniversary of the Journal […]

Professor Gill's team presented three research papers in 31st national conference of Pakistan Society of Gastroenterology being held in Serena , Islamabad from April 3rd to April 5th 2015. One of the study "New treatment of Hepatiits C with Sovaldi and Ribavirin" was given best scientific paper Award by the Society. Professor Gill has congratulated […]

Professor Gill's team has presented five research papers in 24th Asia Pacific association for study of liver diseases (APASL) meeting held in Istanbul Turkey from March 12th to March 15th. Outcomes Of Therapeutic Response To Tenofovir Dipivoxil Fumarate (TDF) In Chronic Hepatitis B Pregnant Patients Muzzaffar Gill*, Sidra Gill, Ammara Nawaz, Misbah Malik, Faiza Irfan […]